Research Options:

Week of Expected Pricing Pending
Company Name BIOLINGUS (CAYMAN) LTD
Proposed Ticker SUBL
CUSIP G1120Y101
Business Description A exempted company with limited liability incorporated under the laws of the Cayman Islands, which is structured as a holding company whose main business operations are conducted through our subsidiaries in Switzerland and to a lesser extent, HK SAR, the People’s Republic of China and Australia. We are a biotechnology company spearheading the development of oral (specifically, sublingual) delivery of peptides and proteins.
Lead Underwriter Univest Securities, LLC
Co-Managers N/A
Initial Shares 30,00,000
Revised Initial Shares 3,60,000
Initial Price $15.00-$16.00
Revised Price $20.00-$20.00
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.